MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
溫馨提示:MGCD-265 (Glesatinib),品質(zhì)穩(wěn)定,純度>98+%,僅供實驗使用.產(chǎn)品質(zhì)量嚴格控制,保證品質(zhì)。
南京百鑫德諾生物科技有限公司
聯(lián)系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!